Common and specific genes in ovarian clear cell carcinoma and serous carcinoma by gene expression analysis

被引:2
作者
Cao, Wenjiao [1 ]
Wang, Lihua [1 ]
机构
[1] Shanghai Jiao Tong Univ, Int Peace Matern & Child Hlth Hosp, Sch Med, China Welf Inst IPMCH, Shanghai 200030, Peoples R China
关键词
Ovarian clear cell carcinoma (CCC); ovarian serous carcinoma (SC); histological subtype; specific genes; gene expression; 2ND PRIMARY TUMORS; POOR-PROGNOSIS; CANCER; PROGRESSION; PROFILES; SURVIVAL; EVENT;
D O I
10.21037/tcr.2018.11.12
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Gene expression profiles differences of clear cell carcinoma (CCC) and serous carcinoma (SC) have been documented, however, these studies usually miss the specific genes changed only in SC or CCC. This study analyzes gene expression profiles of the two histological types and normal ovarian surface epithelium to determine the common and specific genes in these tumors. Methods: The gene expression profiles GSE29450 and GSE36668 were downloaded and analyzed, followed by differentially expressed genes (DEGs) analysis between ovarian cancer and normal samples. Overlap analysis was performed to identify common and specific DEGs in SC and CCC, and then these DEGs were functionally enriched. Subsequently, the protein-protein interaction (PPI) network was constructed on these DEGs and Oncomine analysis was down on select genes. Results: A set of 1,265 DEGs were common to comparisons of each of the two histologic subtypes with normal ovarian surface epithelium, such as ESPL1 and CDC25C, and they were mainly enriched in functions and pathways associated with "chromosome segregation". In addition, 2,971 specific DEGs were identified in the development of ovarian CCC including ribosomes protein genes and other key nodes. Whereas a list of 4,181 DEGs were in SC progression, such as KIT and SYK. Conclusions: The common genes appearing on each ovarian carcinoma subtype's comparison with normal ovarian surface epithelium may benefit to shed light on the common part of molecular mechanisms for ovarian carcinomas pathogenesis. Whereas the specific genes may provide unique targeted therapy for each histological subtype.
引用
收藏
页码:1501 / 1509
页数:9
相关论文
共 50 条
[41]   Proposing a molecular classification associated with hypercoagulation in ovarian clear cell carcinoma [J].
Tamura, Ryo ;
Yoshihara, Kosuke ;
Matsuo, Koji ;
Yachida, Nozomi ;
Miyoshi, Ai ;
Takahashi, Kotaro ;
Sugino, Kentaro ;
Yamaguchi, Manako ;
Mori, Yutaro ;
Suda, Kazuaki ;
Ishiguro, Tatsuya ;
Okuda, Shujiro ;
Motoyama, Teiichi ;
Nakaoka, Hirofumi ;
Kikuchi, Akira ;
Ueda, Yutaka ;
Inoue, Ituro ;
Enomoto, Takayuki .
GYNECOLOGIC ONCOLOGY, 2021, 163 (02) :327-333
[42]   New perspectives on molecular targeted therapy in ovarian clear cell carcinoma [J].
Tan, D. S. P. ;
Miller, R. E. ;
Kaye, S. B. .
BRITISH JOURNAL OF CANCER, 2013, 108 (08) :1553-1559
[43]   Epigenetic determinants of ovarian clear cell carcinoma biology [J].
Yamaguchi, Ken ;
Huang, Zhiqing ;
Matsumura, Noriomi ;
Mandai, Masaki ;
Okamoto, Takako ;
Baba, Tsukasa ;
Konishi, Ikuo ;
Berchuck, Andrew ;
Murphy, Susan K. .
INTERNATIONAL JOURNAL OF CANCER, 2014, 135 (03) :585-597
[44]   The expression of IMP3 in 366 cases with ovarian carcinoma of high grade serous, endometrioid and clear cell subtypes [J].
Lu, Linghui ;
Wang, Shunni ;
Zhu, Qin ;
Qu, Yuqing ;
Gu, Weiyong ;
Ning, Yan ;
Chen, Xiaochen ;
Wang, Yiqin .
PATHOLOGY RESEARCH AND PRACTICE, 2018, 214 (08) :1087-1094
[45]   Immunohistochemical Comparison of Ovarian and Uterine Endometrioid Carcinoma, Endometrioid Carcinoma With Clear Cell Change, and Clear Cell Carcinoma [J].
Lim, Diana ;
Ip, Philip P. C. ;
Cheung, Annie N. Y. ;
Kiyokawa, Takako ;
Oliva, Esther .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2015, 39 (08) :1061-1069
[46]   Loss of ARID1A expression is related to shorter progression-free survival and chemoresistance in ovarian clear cell carcinoma [J].
Katagiri, Atsuko ;
Nakayama, Kentaro ;
Rahman, Mohammed Tanjimur ;
Rahman, Munmun ;
Katagiri, Hiroshi ;
Nakayama, Naomi ;
Ishikawa, Masako ;
Ishibashi, Tomoka ;
Iida, Kouji ;
Kobayashi, Hiroshi ;
Otsuki, Yoshiro ;
Nakayama, Satoru ;
Miyazaki, Kohji .
MODERN PATHOLOGY, 2012, 25 (02) :282-288
[47]   Long-term Survival in Uterine Clear Cell Carcinoma and Uterine Papillary Serous Carcinoma [J].
Lindahl, Bengt ;
Persson, Jan ;
Ranstam, Jonas ;
Willen, Roger .
ANTICANCER RESEARCH, 2010, 30 (09) :3727-3730
[48]   A multi-ethnic analysis of immune-related gene expression signatures in patients with ovarian clear cell carcinoma [J].
Heong, Valerie ;
Tan, Tuan Z. ;
Miwa, Maiko ;
Ye, Jieru ;
Lim, Diana ;
Herrington, C. Simon ;
Iida, Yasushi ;
Yano, Mitsutake ;
Yasuda, Masanori ;
Ngoi, Natalie Y. L. ;
Wong, S. B. Justin ;
Okamoto, Aikou ;
Gourley, Charlie ;
Hasegawa, Kosei ;
Tan, David S. P. ;
Huang, Ruby Y. J. .
JOURNAL OF PATHOLOGY, 2021, 255 (03) :285-295
[49]   Clinical characteristics with patterns of relapse and survival analysis of ovarian clear cell carcinoma [J].
Kaur, S. ;
Kerkar, R. A. ;
Maheshwari, A. ;
Shylasree, T. S. ;
Gupta, S. ;
Deodhar, K. .
INDIAN JOURNAL OF CANCER, 2016, 53 (02) :288-291
[50]   Molecular portraits of clear cell ovarian and endometrial carcinoma with comparison to clear cell renal cell carcinoma [J].
Ackroyd, Sarah A. ;
Arguello, David ;
Ramos, Pilar ;
Mahdi, Haider ;
ElNaggar, Adam ;
Winer, Ira ;
Holloway, Rob ;
Krivak, Thomas ;
Jones, Nathaniel ;
Turner, Valerie Galvan ;
Herzog, Thomas ;
Chu, Christina ;
Brown, Jubilee ;
Mantia-Smaldone, Gina .
GYNECOLOGIC ONCOLOGY, 2023, 169 :164-171